FILE:CAH/CAH-8K-20051102133408.txt.gz
EVENTS:	Regulation FD Disclosure	Financial Statements and Exhibits
TEXT:
ITEM: Regulation FD Disclosure
ITEM: Financial Statements and Exhibits
Table of Contents
 
 
     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (General Instruction A.2. below):
see
      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
o
 
 
Table of Contents
Item 7.01 Regulation FD Disclosure
     Robert D. Walter, Chairman and Chief Executive Officer of Cardinal Health, Inc. (the "Company"), will address shareholders at the Company's 2005 Annual Meeting of Shareholders on Wednesday, November 2 at 2:00 p.m. local time. The Company is furnishing Mr. Walter's slide presentation (the "Walter Slide Presentation") for the Annual Meeting of Shareholders as Exhibit 99.01 to this report. Furnished as Exhibit 99.02 to this report is the GAAP/Non-GAAP reconciliation for the Walter Slide Presentation.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Table of Contents

 
Exhibit 99.01
 
 
 
 
 
 
 
 
 
 
 
 
 

 
Exhibit 99.02
($ millions)
 
 
FREE CASH FLOW ($ millions)
DEFINITIONS:
 
(Earnings from continuing operations + special items after tax) /average shareholders' equity
Return on equity (excluding special items) =
Note: Average shareholders' equity used in the return on equity calculation was $8.7 billion and $7.8 billion in the fourth quarter of fiscal 2005 and 2004, respectively, and $8.4 billion and $7.5 billion for year to date of fiscal 2005 and 2004, respectively.
(Income tax provision + tax effect of special items) / (earnings before income taxes + special items)
Effective tax rate (excluding special items) =
= (Current quarter earnings excluding special items  prior year quarter earnings excluding special items)/ prior year quarter earnings excluding special items
Growth rate (excluding special items)
Current quarter earnings excluding special items / revenue
Ratio to revenue (excluding special items) =
[Operating earnings excluding special items annualized x (1-effective tax rate, excluding special items)] / average (equity +debt + unrecorded goodwill)
Return on invested capital (excluding special items) =
Note: Average unrecorded goodwill used in return on invested capital calculation was $9.7 billion in fiscal 2005 and fiscal 2004.


